# VIGABATRIN
> **ANDA211790** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2022-03-10
## Drug
- **FDA Application Number:** ANDA211790
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** VIGABATRIN
- **Generic name:** Vigabatrin
- **Active ingredients:** VIGABATRIN
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CHARTWELL RX
- **First approval:** 2022-03-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211790)
---
*MORVS · CC0 1.0*